Aldesleukin (Aldesleukin)

Aldesleukin is an interleukin-2 protein produced using recombinant DNA technology (genetic engineering). Improves the functioning of the immune system by encouraging T-lymphocytes to become natural cell killers and thus making them more active in fighting cancer cells. Prescribed by injection. The results of its use in the fight against cancer cells (including melanoma and kidney cancer) are encouraging. Trade name: Proleukin (Prolcukin).

Aldesleukin is a protein that is used to treat cancer. It works as a natural cell killer by stimulating T cells to attack and destroy cancer cells.

Aldesleukin is produced through genetic engineering and can be introduced into the body through injections. Its use in cancer treatment is promising, especially in melanoma and kidney cancer.

The results of using aldesleukin in the fight against cancer have been encouraging, and many patients who have received this drug report improvement in their condition. However, like any other drug, aldesleukin has its side effects and risks, so you should consult your doctor before using it.

Aldesleukin is a protein that can improve the functioning of the immune system and activate the production of T-lymphocytes so that they fight cancerous tumors. This is one of the most powerful immunostimulants in the world. Recombinant DNA makes this possible. The study found that in cancer therapy using antigen-targeted agents, increased levels of IL-2 have a stimulating effect on the antitumor activity of immune cells and this confirms the fact that IL-2 plays a role in cancer immunotherapy. Although Aldesseykin is mainly used for